FallerB., LameireN.Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years.Nephrol Dial Transplant1994; 9: 280–6.
4.
SelgasR., BajoM., Del PesoG., JimenezC.Preserving the peritoneal dialysis membrane in long-term peritoneal dialysis patients.Semin Dial1995; 8: 326–32.
5.
DaviesS., BryanJ., PhillipsL., RussellG.Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis peritonitis.Nephrol Dial Transplant1996; 11: 498–506.
6.
RubinJ., HerreraG.A., CollinsD.An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis.Am J Kidney Dis1991; 18: 97–102.
7.
DobbieJ., AndersonJ., HindC.Long-term effects of peritoneal dialysis on peritoneal morphology.Perit Dial Int1994; 14(Suppl 3): S16–20.
8.
SchnebleF., BonzelK.E., WaldherrR., BachmannS., RothH., ScharerK.Peritoneal morphology in children treated by continuous ambulatory peritoneal dialysis.Pediatr Nephrol1992; 6: 542–6.
9.
DobbieJ.W.Morphology of the peritoneum in CAPD.Blood Purif1989; 7: 74–85.
10.
Di PaoloN., SacchiG., De MiaM., GaggiottiE., CapotondoL., RossiP.Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis.Nephron1986; 44: 204–11.
11.
Di PaoloN., SacchiG.Anatomy and physiology of the peritoneal membrane.Contrib Nephrol1990; 84: 10–26.
DobbieJ.W.Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis.Perit Dial Int1992; 12: 14–27.
18.
DeebL.S., MouradF.H., El-ZeinY.R., UthmanS.M.Abdominal cocoon in a man: Preoperative diagnosis and literature review.J Clin Gastroenterol1998; 26: 148–50.
19.
LevineS., SaltzmanA.Abdominal cocoon: An animal model for a complication of peritoneal dialysis.Perit Dial Int1996; 16: 613–16.
HauglustaineD., MonballyuJ., van MeerbeekJ., GoddeerisP., LauwerijnsJ., MichielsenP.Sclerosing obstructive peritonitis, beta-blockers, and continuous ambulatory peritoneal dialysis.Lancet1983; 2: 733–4.
31.
NakamotoM.Pathogenesis of peritoneal fibrosis and peritoneal small vessel changes.Perit Dial Int1996; 16(Suppl 1): S39–41.
32.
KraneS.M., GoldringM.B.Potential role for interleukin-1 in fibrosis associated with chronic ambulatory peritoneal dialysis.Blood Purif1988; 6: 173–7.
33.
RobertsJ.D., NewmanR.A., KimberlyP.J., HackerM.P.Regional fibrosis after intraperitoneal administration of mafosfamide.Invest New Drugs1986; 4: 61–5.
34.
MyllarniemiH., LeppaniemiA.Peritoneal fibrosis due to practolol. Scanning electron microscopical and histological observations.Acta Chir Scand1981; 147: 137–42.
35.
CelicoutB., LevardH., HayJ., MsikaS., FingerhutA., PelissierE.Sclerosing encapsulating peritonitis: Early and late results of surgical management in 32 cases. French Associations for Surgical Research.Dig Surg1998; 15: 697–702.
36.
YokotaS., KumanoK., SakaiT.Prognosis for patients with sclerosing encapsulating peritonitis following CAPD.Adv Perit Dial1997; 13: 221–3.
AfthentopoulosI.E., PassadakisP., OreopoulosD.G., BargmanJ.Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: One center's experience and review of the literature (Published erratum appears in Adv Ren Replace Ther 1998; 5: 353).Adv Ren Replace Ther1998; 5: 157–67.
39.
WeberJ., MettangT., Mayer–WehrsteinR., KuhlmannU.[Continuous ambulatory peritoneal dialysis. Patient and method survival rate, peritonitis incidence and dialysis efficacy over 10 years]. German.Dtsch Med Wochenschr1991; 116: 641–8.
GreenbergA., BernardiniJ., PirainoB.M., JohnstonJ.R., PerlmutterJ.A.Hemoperitoneum complicating chronic peritoneal dialysis: Single-center experience and literature review.Am J Kidney Dis1992; 19: 252–6.
42.
OulesR., ChallahS., BrunnerF.P.Case-control study to determine the cause of sclerosing peritoneal disease.Nephrol Dial Transplant1988; 3: 66–9.
43.
RigbyR.J., HawleyC.M.Sclerosing peritonitis: The experience in Australia.Nephrol Dial Transplant1998; 13: 154–9.
44.
NomotoY., KawaguchiY., KuboH., HiranoH., SakaiS., KurokawaK.Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: A report of the Japanese Sclerosing Encapsulating Peritonitis Study Group.Am J Kidney Dis1996; 28: 420–7.
45.
MasudaC., FujiiY., KamiyaT., MiyamotoM., NakaharaK., HattoriS.Idiopathic sclerosing peritonitis in a man.Intern Med1993; 32: 552–5.
46.
GenereauT., BellinM.F., WechslerB., LeT.H., BellangerJ., GrelletJ.Demonstration of efficacy of combining corticosteroids and colchicine in two patients with idiopathic sclerosing mesenteritis.Dig Dis Sci1996; 41: 684–8.
47.
Pallas RegueiraJ.A., Cortes EncinasF., JordaM., Caro PerezF., CamposJ., BotellaJ.A.[Idiopathic sclerosing peritonitis (ISP). A report of a new case and a review of the literature]. Spanish.Rev Esp Enferm Dig1992; 82: 434–7.
ChangA.R.Test and teach. Number twenty-one. Diagnosis: Practolol induced sclerosing peritonitis.Pathology1980; 12: 32–3, 131–3.
60.
NancarrowJ.F.Sclerosing peritonitis and timolol (Letter).Lancet1978; 2: 525–6.
61.
HartyR.F.Sclerosing peritonitis and propranolol.Arch Intern Med1978; 138: 1424–6.
62.
Baxter–SmithD.C., MonypennyI.J., DorricottN.J.Sclerosing peritonitis in patient on timolol (Letter).Lancet1978; 2: 149.
63.
DickH.M., WrightP., ChapmanC.M., ZachariasF.J., NichollsJ.T.Adverse reactions to practolol: Some observations on the possible relevance to immune mechanisms.Allergy1978; 33: 71–5.
BaddeleyM., LeeR.E., MarshallA.J., ReadA.E.Sclerosing peritonitis due to practolol (Letter).Br Med J1977; 2: 192.
66.
ThompsonR.P., JacksonB.T.Sclerosing peritonitis due to practolol.Br Med J1977; 1: 1393–4.
67.
EltringhamW.K., EspinerH.J., WindsorC.W., GriffithsD.A., DaviesJ.D., BaddeleyH.Sclerosing peritonitis due to practolol: A report on 9 cases and their surgical management.Br J Surg1977; 64: 229–35.
68.
JacksonB.T.Surgical treatment of sclerosing peritonitis caused by practolol.Br J Surg1977; 64: 255–7.
69.
PantingA.L., DenhamH.E.Drug-induced sclerosing peritonitis.N Z Med J1977; 85: 10–12.
70.
CookA.I., FoyP.Sclerosing peritonitis and practolol therapy.Ann R Coll Surg Engl1976; 58: 473–5.
71.
DunlopJ.M., LoganH.Sclerosing peritonitis due to practolol simulating an ovarian tumour.Ulster Med J1976; 45: 180–8.
72.
BraamJ.I., ReismaK., LuikenH.C., van HeesC.A., Oeberius KapteynJ.L., HenneveldH.E.[Sclerosing peritonitis following the use of practolol (Eraldin)]. Dutch.Ned Tijdschr Geneeskd1975; 119: 1000–5.
73.
KristensenK., KristensenJ.S., ThorborgJ.V.Letter: Fractolol and sclerosing peritonitis.Lancet1975; 1: 741–2.
74.
MeyboomR.H.Letter: Practolol and sclerosing peritonitis.Lancet1975; 1: 334–5.
75.
BrownP., BaddeleyH., ReadA.E., DaviesJ.D., McGarryJ.Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol).Lancet1974; 2: 1477–81.
76.
SlingeneyerA.Preliminary report on a cooperative international study on sclerosing encapsulating peritonitis.Contrib Nephrol1987; 57: 239–47.
NgoY., MessingB., MarteauP., NouelO., PasquiouA., LavergneA.Peritoneal sarcoidosis. An unrecognized cause of sclerosing peritonitis.Dig Dis Sci1992; 37: 1776–80.
82.
NadorraR.L., NakazatoY., LandingB.H.Pathologic features of gastrointestinal tract lesions in childhood-onset systemic lupus erythematosus: Study of 26 patients, with review of the literature.Pediatr Pathol1987; 7: 245–59.
83.
BinderS.C., DeterlingR.A.Jr., MahoneyS.A., PattersonJ.F., WolfeH.J.Systemic idiopathic fibrosis. Report of a case of the concomitant occurrence of retractile mesenteritis and retroperitoneal fibrosis.Am J Surg1972; 124: 422–30.
84.
RenvallS., LehtoM., PenttinenR.Development of peritoneal fibrosis occurs under the mesothelial cell layer.J Surg Res1987; 43: 407–12.
85.
ClarkC.V., TerrisR.Sclerosing peritonitis associated with metoprolol (Letter).Lancet1983; 1: 937.
86.
BorgonovoG., De MariniL., ForforiP., AbeteM., AmatoA., TorreG.C.[Complications after the LeVeen peritoneovenous shunt]. Italian.Minerva Med1987; 78: 705–16.
87.
NattN., HeufelderA.E., HayI.D., GrantC.S., GoellnerJ.R.Extracervical fibrosclerosis causing obstruction of a ventriculo-peritoneal shunt in a patient with hydrocephalus and invasive fibrous thyroiditis (Riedel's struma).Clin Endocrinol (Oxf)1997; 47: 107–11.
88.
StanleyM.M., ReyesC.V., GreenleeH.B., NemchauskyB., ReinhardtG.F.Peritoneal fibrosis in cirrhotics treated with peritoneovenous shunting for ascites. An autopsy study with clinical correlations.Dig Dis Sci1996; 41: 571–7.
89.
LaFerlaG., McCollK.E., CreanG.P.CSF induced sclerosing peritonitis: A new entity?Br J Surg1986; 73: 77.
90.
ReginellaR.F., SumkinJ.H.Sclerosing peritonitis associated with luteinized thecomas.AJR Am J Roentgenol1996; 167: 512–13.
91.
IwasaY., MinamiguchiS., KonishiI., OnoderaH., ZhouJ., YamabeH.Sclerosing peritonitis associated with luteinized thecoma of the ovary.Pathol Int1996; 46: 510–14.
92.
WernessB.A.Luteinized thecoma with sclerosing peritonitis.Arch Pathol Lab Med1996; 120: 303–6.
93.
ClementP.B., YoungR.H., HannaW., ScullyR.E.Sclerosing peritonitis associated with luteinized thecomas of the ovary. A clinicopathological analysis of six cases.Am J Surg Pathol1994; 18: 1–13.
94.
StenramU.Sclerosing peritonitis in a case of benign cystic ovarian teratoma. A case report.APMIS1997; 105: 414–16.
95.
FrigerioL., TaccagniG.L., MarianiA., MangiliG., FerrariA.Idiopathic sclerosing peritonitis associated with florid mesothelial hyperplasia, ovarian fibromatosis, and endometriosis: A new disorder of abdominal mass.Am J Obstet Gynecol1997; 176: 721–2.
ArumugamK., YipY.C.De novo formation of adhesions in endometriosis: the role of iron and free radical reactions.Fertil Steril1995; 64: 62–4.
98.
KaumaS., ClarkM.R., WhiteC., HalmeJ.Production of fibronectin by peritoneal macrophages and concentration of fibronectin in peritoneal fluid from patients with or without endometriosis.Obstet Gynecol1988; 72: 13–18.
99.
ShintakuM., BabaY., FujiwaraT.Intra-abdominal desmoplastic small cell tumour in a patient with Peutz–Jeghers syndrome.Virchows Arch1994; 425: 211–15.
100.
ScurryJ., AllenD., DobsonP.Ovarian fibromatosis, ascites and omental fibrosis.Histopathology1996; 28: 81–4.
101.
RevelliE., MacchioniB., SbriglioV.S.[Sterility caused by periovarian and ovarian fibrosis due to the results of pelvic tubercular phlogosis]. Italian.Minerva Ginecol1965; 17: 1115–22.
102.
SieratzkiJ., SchneiderM., MullerH.[Disseminated fibromatosis of the mesenterium]. German.Leber Magen Darm1985; 15: 90–2.
103.
CoxS.V., LaiJ., SuranyiM., WalkerN.Sclerosing peritonitis with gross peritoneal calcification: A case report.Am J Kidney Dis1992; 20: 637–42.
WirnsbergerG.H., GanserK., DomejW., SausengG., MooreD., MoczygembaM.Sclerosing encapsulating peritonitis: Differential diagnosis to peritoneal encapsulation and abdominal cocoon — a case report.Z Gastroenterol1992; 30: 534–7.
106.
CostantinidesF., Di NunnoN., BernasconiP., JonjicN., MelatoM.A new type of peritoneal encapsulation of the small bowel (Letter).Am J Surg Pathol1998; 22: 1297–8.
107.
HoringE., HingerlT., HensK., von GaisbergU., KieningerG.Protein-losing enteropathy: First manifestation of sclerosing mesenteritis.Eur J Gastroenterol Hepatol1995; 7: 481–3.
ThompsonB.W., ReadR.C.Sclerosing cholangitis and other intra-abdominal fibroses.Am J Surg1974; 128: 777–81.
110.
Parra–DavilaE., McKenneyM.G., SleemanD., HartmannR., RaoR.K., McKenneyK.Mesenteric panniculitis: Case report and literature review.Am Surg1998; 64: 768–71.
111.
YashiroM., ChungY.S., NishimuraS., InoueT., SowaM.Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as “soil” for peritoneal dissemination.Cancer1996; 77(8 Suppl): 1668–75.
112.
LundinC., SullinsK.E., WhiteN.A., ClemM.F., DebowesR.M., PfeifferC.A.Induction of peritoneal adhesions with small intestinal ischaemia and distention in the foal (see Comments).Equine Vet J1989; 21: 451–8.
GoldR.S., MuchaS.J.Unique case of mesenteric fibrosis in multiple polyposis.Am J Surg1975; 130: 366–9.
117.
JeffreyR.B.Jr.Imaging of the peritoneal cavity.Curr Opin Radiol1991; 3: 471–3.
118.
VuongP.N., GuyotH., MoulinG., Houissa–VuongS., BerrodJ.L.Pseudotumoral organization of a twisted epiploic fringe or ‘hard-boiled egg’ in the peritoneal cavity.Arch Pathol Lab Med1990; 114: 531–3.
ButtnerA., BasslerR., TheeleC.Pregnancy-associated ectopic decidua (deciduosis) of the greater omentum. An analysis of 60 biopsies with cases of fibrosing deciduosis and leiomyomatosis peritonealis disseminata.Pathol Res Pract1993; 189: 352–9.
124.
DawsonA., GibbsA.R., PooleyF.D., GriffithsD.M., HoyJ.Malignant mesothelioma in women.Thorax1993; 48: 269–74.
125.
TsutsumiA., KawabataK., TaguchiK., DoiK.Elastofibroma of the greater omentum.Acta Pathol Jpn1985; 35: 233–41.
126.
SuzukiY., KohyamaN.Malignant mesothelioma induced by asbestos and zeolite in the mouse peritoneal cavity.Environ Res1984; 35: 277–92.
RobertsJ.D., NewmanR.A., KimberlyP.J., HackerM.P.Regional fibrosis after intraperitoneal administration of mafosfamide.Invest New Drugs1986; 4: 61–5.
129.
SugarbakerP.H., LandyD., JaffeG., PascalR.Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix.Cancer1990; 65: 1495–501.
130.
MarkmanM., ClearyS., HowellS.B., LucasW.E.Complications of extensive adhesion formation after intra-peritoneal chemotherapy.Surg Gynecol Obstet1986; 162: 445–8.
131.
MoriH., TanakaH., KawadaK., NagaiH., KodaA.Suppressive effects of tranilast on pulmonary fibrosis and activation of alveolar macrophages in mice treated with bleomycin: Role of alveolar macrophages in the fibrosis.Jpn J Pharmacol1995; 67: 279–89.
132.
HastieK., RamesarK., CuschieriA.Local and systemic effects of repeated intraperitoneal epirubicin treatment.Eur J Surg Oncol1991; 17: 379–83.
133.
PotkulR.K., GondalJ., BittermanP., DretchenK.L., RahmanA.Toxicities in rats with free versus liposomal encapsulated cisplatin.Am J Obstet Gynecol1991; 164: 652–8.
134.
ZakrisE.L., DewhirstM.W., RiviereJ.E., HoopesP.J., PageR.L., OlesonJ.R.Pharmacokinetics and toxicity of intra-peritoneal cisplatin combined with regional hyperthermia.J Clin Oncol1987; 5: 1613–20.
SullivanJ.M., JanovitzE.B., RobinsonF.R.Copper toxicosis in veal calves.J Vet Diagn Invest1991; 3: 161–4.
138.
GoodmanD.G., WardJ.M., ReichardtW.D.Splenic fibrosis and sarcomas in F344 rats fed diets containing aniline hydrochloride, p-chloroaniline, azobenzene, o-toluidine hydrochloride, 4,4'-sulfonyldianiline, or D & C red No. 9.J Natl Cancer Inst1984; 73: 265–73.
139.
CastelliM.J., ArminA.R., HusainA., OrfeiE.Fibrosing peritonitis in a drug abuser.Arch Pathol Lab Med1985; 109: 767–9.
140.
DaviesR., SkidmoreJ.W., GriffithsD.M., MoncrieffC.B.Cytotoxicity of talc for macrophages in vitro.Food Chem Toxicol1983; 21: 201–7.
141.
BlejerH.P., ArlonR.Talc: A possible occupational and environmental carcinogen.J Occup Med1973; 15(2): 92–7.
DonaldsonK.Short-term animal studies for detecting inflammation, fibrosis and pre-neoplastic changes induced by fibres.IARC Sci Publ1996; 140: 97–106.
144.
FriemannJ., MullerK.M., PottF.Mesothelial proliferation due to asbestos and man-made fibres. Experimental studies on rat omentum.Pathol Res Pract1990; 186: 117–23.
145.
EhrenreichT., SelikoffI.J.Diseases associated with asbestos exposure. Diagnostic perspectives in forensic pathology.Am J Forensic Med Pathol1983; 4: 63–72.
146.
GrossP.Is short-fibered asbestos dust a biological hazard?Arch Environ Health1974; 29: 115–17.
147.
JagaticJ., RubnitzM.E., GodwinM.C., WeiskopfR.W.Tissue response to intraperitoneal asbestos with preliminary report of acute toxicity of heat-treated asbestos in mice.Environ Res1967; 1: 217–30.
148.
LeeH.G., ChoiI., PyunK.H., ParkK.W.Peritoneal lavage fluids stimulate NIH3T3 fibroblast proliferation and contain increased tumour necrosis factor and IL-6 in experimental silica-induced rat peritonitis.Clin Exp Immunol1995; 100: 139–44.
KeatingJ.P., NeillM., HillG.L.Sclerosing encapsulating peritonitis after intraperitoneal use of povidone iodine.Aust N Z J Surg1997; 67: 742–4.
152.
MackowR.C., ArgyW.P., WinchesterJ.F., RakowskiT.A., FieldsP.A., RotellarC.Sclerosing encapsulating peritonitis in rats induced by long-term intraperitoneal administration of antiseptics.J Lab Clin Med1988; 112: 363–71.
153.
MackowR.C., WinchesterJ.F., ArgyW.P., AndrewsP.M., FieldsP.A., BatesS.Sclerosing encapsulating peritonitis in rats: An experimental study with intraperitoneal antiseptics.Contrib Nephrol1987; 57: 213–18.
154.
LoW.K., ChanK.T., LeungA.C., PangS.W., TseC.Y.Sclerosing peritonitis complicating continuous ambulatory peritoneal dialysis with the use of chlorhexidine in alcohol.Adv Perit Dial1990; 6: 79–84.
155.
McLaughlinK., ButtG., MadiA., McMillanM., MactierR.Sclerosing peritonitis occurring in a hemodialysis patient.Am J Kidney Dis1996; 27: 729–32.
156.
SlingeneyerA., MionC., MouradG., CanaudB., FallerB., BeraudJ.J.Progressive sclerosing peritonitis: A late and severe complication of maintenance peritoneal dialysis.Trans Am Soc Artif Intern Organs1983; 29: 633–40.
157.
PerfumoF., AltieriP., Degl'InnocentiM.L., GhiggeriG.M., CaridiG., TrivelliA.Effects of peritoneal effluents on mesothelial cells in culture: Cell proliferation and extracellular matrix regulation.Nephrol Dial Transplant1996; 11: 1803–9.
158.
VergerC., CelicoutB., LarpentL., GoupilA.[Encapsulating peritonitis during continuous ambulatory peritoneal dialysis. A physiopathologic hypothesis].Presse Med1986; 15: 1311–14.
159.
ChewC.G., ClarksonA.R., FaullR.J.Relapsing CAPD peritonitis with rapid peritoneal sclerosis due to Haemophilus influenzae.Nephrol Dial Transplant1997; 12: 821–2.
160.
HuangC.H., ChenH.S., ChenY.M., TsaiT.J.Fibroadhesive form of tuberculous peritonitis: Chyloperitoneum in a patient undergoing automated peritoneal dialysis.Nephron1996; 72: 708–11.
161.
ParkM.S.Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.Adv Ren Replace Ther1998; 5: 185–93.
162.
LinC.Y., ChenW.P., FuL.W., YangL.Y., HuangT.P.Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.Adv Perit Dial1997; 13: 64–71.
163.
VeechR.L., GitomerW.L.The medical and metabolic consequences of administration of sodium acetate.Adv Enzyme Regul1988; 27: 313–43.
164.
BingelM., LonnemannG., KochK.M., DinarelloC.A., ShaldonS.Enhancement of in-vitro human interleukin-1 production by sodium acetate.Lancet1987; 1: 14–16.
165.
SugaH., TeraokaS., OtaK., KomemushiS., FurutaniS., YamauchiS.Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats.Exp Toxicol Pathol1995; 47: 287–91.
166.
JunorB.J., McMillanM.A.Immunosuppression in sclerosing peritonitis.Adv Perit Dial1993; 9: 187–9.
167.
LoW.K., ChanK.T., LeungA.C., PangS.W., TseC.Y.Sclerosing peritonitis complicating prolonged use of chlorhexidine in alcohol in the connection procedure for continuous ambulatory peritoneal dialysis.Perit Dial Int1991; 11: 166–72.
168.
SabatiniS., FracassoA., BazzatoG., KurtzmanN.A.Effect of phthalate acid esters on transport in toad bladder membrane.J Pharmacol Exp Ther1989; 250: 910–14.
169.
FracassoA., ColiU., LandiniS., MorachielloP., RighettoF., ScanferlaF.Peritoneal sclerosis. Role of plasticizers.ASAIO Trans1987; 33: 676–82.
170.
FracassoA., BaggioB., OssiE., Del PreteD., BonfanteL., BazzatoG.Glycosaminoglycans prevent the functional and morphological peritoneal derangement in an experimental model of peritoneal fibrosis.Am J Kidney Dis1999; 33: 105–10.
171.
CarozziS., NasiniM.G., SchelottoC., CavigliaP.M., SantoniO., PietrucciA.A biocompatibility study on peritoneal dialysis solution bags for CAPD.Adv Perit Dial1993; 9: 138–42.
172.
KumanoK., SchillerB., HjelleJ.T., MoranJ.Effects of osmotic solutes on fibronectin mRNA expression in rat peritoneal mesothelial cells.Blood Purif1996; 14: 165–9.
173.
WangT., ChenY.G., YeR.G., LiS.L., LiH.Q., ChenY.X.Effect of glucose on TGF-beta 1 expression in peritoneal mesothelial cells.Adv Perit Dial1995; 11: 7–10.
174.
WangT., GhenY.G., YeR.G., MaiW.Y., ZhenZ.H., LiH.Q.Enhanced expression of TGF-beta 1 by peritoneal macrophages in CAPD patients.Adv Perit Dial1995; 11: 11–14.
175.
KnowlesK.Acute abdominal pain in a dialysis patient.Hosp Pract (Off Ed)1992; 27: 160, 162.
176.
HauglustaineD., van MeerbeekJ., MonballyuJ., GoddeerisP., LauwerijnsJ., MichielsenP.Sclerosing peritonitis with mural bowel fibrosis in a patient on long-term CAPD.Clin Nephrol1984; 22: 158–62.
177.
KredietR.T., StruijkD.G., BoeschotenE.W., KoomenG.C., StouthardJ.M., HoekF.J.The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis.Am J Kidney Dis1989; 13: 299–307.
Stafford–JohnsonD.B., WilsonT.E., FrancisI.R., SwartzR.CT appearance of sclerosing peritonitis in patients on chronic ambulatory peritoneal dialysis.J Comput Assist Tomogr1998; 22: 295–9.
180.
LoughreyG.J., HawnaurJ.M., SambrookP.Case report: Computed tomographic appearance of sclerosing peritonitis with gross peritoneal calcification (see Comments).Clin Radiol1997; 52: 557–8.
181.
KrestinG.P., KaclG., HauserM., KeuschG., BurgerH.R., HoffmannR.Imaging diagnosis of sclerosing peritonitis and relation of radiologic signs to the extent of the disease.Abdom Imaging1995; 20: 414–20.
182.
KrestinG.P., KaclG., HoffmannR., KeuschG., BurgerH.R.[The imaging diagnosis of sclerosing peritonitis (SP) following continuous ambulatory peritoneal dialysis (CAPD)]. German.Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr1992; 157: 506–11.
183.
HollmanA.S., McMillanM.A., BriggsJ.D., JunorB.J., MorleyP.Ultrasound changes in sclerosing peritonitis following continuous ambulatory peritoneal dialysis.Clin Radiol1991; 43: 176–9.
184.
KorzetsA., KorzetsZ., PeerG., PapoJ., SternD., BernheimJ.Sclerosing peritonitis. Possible early diagnosis by computerized tomography of the abdomen.Am J Nephrol1988; 8: 143–6.
185.
JeffreyR.B.Jr.Imaging of the peritoneal cavity.Curr Opin Radiol1991; 3: 471–3.
AssaliaA., ScheinM., HashmonaiM.Problems in the surgical management of sclerosing encapsulating peritonitis.Isr J Med Sci1993; 29: 686–8.
191.
VergerC., BrunschvicgO., Le CharpentierY., LavergneA., VantelonJ.Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.Proc Eur Dial Transplant Assoc1981; 18: 199–205.
192.
HondaK., NittaK., HoritaS., YumuraW., NiheiH.Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure.Nephron1996; 72: 171–6.
193.
LubbertE., ZimmeringM., KirchmairF., FillerG., TennstedtC., RudolphB.Successful surgical treatment of sclerosing peritonitis persisting after renal transplantation (Letter).Pediatr Nephrol1998; 12: 525–6.
194.
PusateriR., RossR., MarshallR., MeredithJ.H., HamiltonR.W.Sclerosing encapsulating peritonitis: Report of a case with small bowel obstruction managed by long-term home parenteral hyperalimentation, and a review of the literature.Am J Kidney Dis1986; 8: 56–60.
JacksonB.T.Surgical treatment of sclerosing peritonitis caused by practolol.Br J Surg1977; 64: 255–7.
197.
MoriY., MatsuoS., SutohH., ToriyamaT., KawaharaH., HottaN.A case of a dialysis patient with sclerosing peritonitis successfully treated with corticosteroid therapy alone.Am J Kidney Dis1997; 30: 275–8.
198.
BhandariS., WilkinsonA., SellarsL.Sclerosing peritonitis: Value of immunosuppression prior to surgery.Nephrol Dial Transplant1994; 9: 436–7.
199.
BhandariS.Recovery of gastrointestinal function after renal transplantation in patients with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis.Am J Kidney Dis1996; 27: 604.
HawleyC.M., WallD.R., JohnsonD.W., CampbellS.B., GriffinA.D., RigbyR.J.Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis.Am J Kidney Dis1995; 26: 658–61.
202.
AllariaP.M., GiangrandeA., GandiniE., PisoniI.B.Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: Tamoxifen as a new therapeutic agent?J Nephrol1999; 12: 395–307.
